Career Search
Explore opportunities with Novartis below.
Notice to applicants for US job openings. Learn More
Showing 47 results
- Sort by Sort ascending
- Job Title Sort ascending
- Business
- Location
- Site
- Date Posted
Job Title Sort ascending | Business | Location | Site | Date Posted |
---|---|---|---|---|
Field Excellence Manager (m/w/d) Regulär, Full time | Innovative Medicines | Germany | Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) | Jun 13, 2024 |
Pharmareferent (m/w/d), Hematology, Gebiet: Essen, NRW Regulär (Außendienst), Full time | Innovative Medicines | Germany | North Rhine-Westphalia (Novartis Pharma GmbH) | Jun 13, 2024 |
Scientific Education Manager (m/w/d) Regulär, Full time | Innovative Medicines | Germany | Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) | Jun 12, 2024 |
Network Manager Prostate Cancer (m/w/d) Hannover, Braunschweig, Bremen, Göttingen Regulär (Außendienst), Full time | Innovative Medicines | Germany | Lower Saxony (Novartis Pharma GmbH) | Jun 11, 2024 |
Sales Representative (d/w/m)-TA: Onkologie, Niedersachsen Regulär (Außendienst), Full time | Innovative Medicines | Germany | Lower Saxony (Novartis Pharma GmbH) | Jun 11, 2024 |
Sales Representative Brustkrebs (d/w/m) Hessen Regulär (Außendienst), Full time | Innovative Medicines | Germany | Hessen (Novartis Pharma GmbH) | Jun 02, 2024 |
Employment Tax Manager (m/w/d) Regulär, Full time | Corporate | Germany | Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) | May 29, 2024 |
Pharmareferent (d/w/m), TA: Cardio, Gebiet: Bezirk Gelsenkirchen Regular (Sales), Full time | Innovative Medicines | Germany | North Rhine-Westphalia (Novartis Pharma GmbH) | May 28, 2024 |
Pharmareferent (d/w/m), TA: Cardio, Gebiet: Bezirk Gelsenkirchen Regulär (Außendienst), Full time | Innovative Medicines | Germany | North Rhine-Westphalia (Novartis Pharma GmbH) | May 28, 2024 |
Pharmareferent (d/w/m), TA: Cardio, Gebiet: Bezirk Gelsenkirchen Regular (Ventas), Full time | Innovative Medicines | Germany | North Rhine-Westphalia (Novartis Pharma GmbH) | May 28, 2024 |